StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.25−0.01 (-0.31%)

Close on Nov 18, 2026Market cap $23.95MP/E –Yield –

Immutep revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2026 it was A$24.17M, up 133.9% from the year before. Over ten years it grew 28.1% a year on average. The highest annual figure on record is A$24.17M in fiscal 2026.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$24.17M+133.9%
FY2025Jun 30, 2025A$10.33M+31.8%
FY2024Jun 30, 2024A$7.84M+50.7%
FY2023Jun 30, 2023A$5.20M-23.1%
FY2022Jun 30, 2022A$6.76M+70.3%
FY2021Jun 30, 2021A$3.97M-76.0%
FY2020Jun 30, 2020A$16.50M+120.3%
FY2019Jun 30, 2019A$7.49M+1.9%
FY2018Jun 30, 2018A$7.35M+74.2%
FY2017Jun 30, 2017A$4.22M+108.1%
FY2016Jun 30, 2016A$2.03M–

More Immutep figures

See a number that looks wrong?